Ch.26: NSAIDs (Vickroy) Flashcards

1
Q

What are NSAIDs?

A

anti-inflammatory drugs that are clinically and biologically distinct from glucocorticoid steroids (“non-steroidal”)

  • produce analgesic and anti-pyretic (lower fever) actions at low dose, and anti-inflamm. action at high dose
  • VERY widely used
  • originally isolated from white willow tree
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NSAIDs all act via which mech.?

A

inhibition of intracellular cyclooxygenase enzymes COX-1 and/or COX-2 –> disrupted metabolism of arachidonic acid –> inhibited synthesis of intracellular autacoids (prostaglandins, thromboxanes, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Major clinical uses of NSAIDs

A

-acute pain (i.e. post-sx, colic, lesions, pancreatitis, etc.)
-chronic pain
-inflammation
-mastitis, metritis, endotoxemia (along with abx)
-fever
-atherosclerosis (plaque build-up in arteries; humans)
-neurodegenerative disorders (humans)
+/- cancer
*chronic use is usually to alleviate pain, not inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

first COX-2 selective inhibitor

A

celebrex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

first NSAID

A

aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

phospholipase

A

enzyme released when cell lipid bi-layer damaged by physical/chemical insults, toxin, temp. change, oxides, etc.
*catalyzes the breakdown of membrane phospholipids and releases numerous by-products, including arachidonic acid (AA), which is the precursor for eicosanoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

arachidonic acid is the precursor for:*

A

eicosanoids (signalling molecules that exert complex control over many bodily systems, mainly in inflammation or immunity, and as messengers in the central nervous system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

“dual inhibitors” inhibit which 2 pathways?

A

lipoxygenase and COX pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

are there single or multiple receptors for eicanosoids? What kind of receptor(s) are they?

A

multiple. G protein-coupled receptors located on various target tissue cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

in general, is it better to selectively inhibit COX-1 or 2?

A

COX-2. COX-1 is important for “housekeeper roles” in homeostasis and is gastro/renal protective, whereas COX-2 is mostly a product of inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

products of COX-1*

A

thromboxane-A2
PGE2
PGI2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is COX-1 always present on cells? COX-2?

A

COX-1 always present (“constitutive”)
COX-2 is present mostly during inflammation only, besides some constitutive expression on monos, macs, endothelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

advantage of COX-2 selective inhibitors*

A

lower incidence of GI, renal problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NSAIDs interfere with which chemical mediators?

A
Eicosanoids
Kinins
Cytokines
Chemokines
Fibrinopeptides (?)
*Key point: they are NOT just COX-inhibitors; they have many other actions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glucocorticoids interfere with which chemical mediators?

A
lysosomal release
eicosanoids
platelet-activating factors
complement
cytokines
chemokines
*they are NOT just COX-inhibitors; they have many other actions (probably DNM list)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Most common side effects of NSAIDs**

A

*gastropathy
nephrotoxicity (acute renal failure)
idiosyncratic reactions (bone marrow depression, skin rxns, etc.)

lesser extent: blood dyscrasias, hepatotoxicity, delayed healing (soft tissue and bone)
*most NSAIDs fairly safe to use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How to prevent nephrotoxicity with NSAIDs?

A

good hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2 main determinants of how bad NSAID adverse effect will be***

A

DOSE and TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

2 main populations of dogs administered NSAIDs

A

dogs with osteoarthritis

post-op dogs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

adverse drug experience

A

any adverse event assoc. with the use of a new animal drug, whether or not considered to be drug related, and whether or not the new animal drug was used in accordance with the approved labeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

chem. properties of NSAIDs

A
  • synthetic organic acids
  • good lipid solubility
  • stable in GI tract*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

risk factors of giving osteoarthritis dog NSAID

A

geriatrics, concomitant hepatic/renal/etc. dz

23
Q

risk factors of giving post-op dog NSAID

A

poor hydration, may have compromised renal fx

24
Q

pharmacokinetic props. of NSAIDs

A
  • highly protein bound*
  • lvl in milk enhanced during mastitis (due to pH effect, protein binding)
  • good oral absorption*
  • distr. limited for MOST NSAIDs due to extremely high plasma protein binding (exception = flunixin)
25
Q

therapeutic advantage of high NSAID protein binding*

A

likely to accumulate in inflammatory exudate, which has high protein content
-actions persist longer than expected relative to plasma levels*

26
Q

penetration of NSAIDs into milk is LOW/HIGH for norm. mammary tissue? Why?

A

LOW (lack of ion trapping, high protein binding)

27
Q

metabolism of NSAIDs

A

mostly hepatic metabolism

protein binding limits renal excretion

28
Q

Name 1 NSAID with a higher volume of distribution?

A

flunixin (cattle)

29
Q

Required NSAIDs

A
carprofen
deracoxib
flunixin meglumine
ketoprofen
phenylbutazone
tepoxalin
(all in hospital formulary)
30
Q

Is carprofen a selective/non-selective COX-inhibitor?*

A

non-selective

31
Q

Carprofen approved in which animals?

A

dogs only

32
Q

Carprofen side effects and their management

A

GI, renal, hepatic. Higher incidence in Labs

Manage via periodic bloodwork, using wash-out period before switching to another NSAID

33
Q

ketoprofen selective/non-selective COX inhibitor?*

A

non-selective

34
Q

Ketoprofen approved in which animals?*

A

horses**
dogs
cats in Canada only

35
Q

Most common use of ketoprofen in dogs

A

peri or post-operativey

36
Q

Ketoprofen side effects

A

Dogs: GI
Horse: GI/renal complications

37
Q

“coxib” at end of drug name indicates:

A

it is a SELECTIVE COX inhibitor

38
Q

Deracoxib approved in which animals?

A

dogs only

39
Q

Deracoxib selective/non-selective?

A

selective for COX-2

40
Q

Deracoxib side effects

A

generally well tolerated; watch for sulfonamide hypersensitivity

41
Q

Most common uses of Deracoxib

A

post-op pain from orthopedic or dental sx and osteoarthritis in dogs

42
Q

most broadly used NSAID in large animal*

A

flunixin meglumine

43
Q

Flunixin used in which species

A
horses, swine, cattle
NO dogs (they are sensitive to GI damage)
44
Q

flunixin selective/non-selective COX inhib?*

A

non-selective

45
Q

Major uses of flunixin

A
  • MS pain, inflamm.
  • pyrexia (fever), mastitis, endotoxemia
  • colic
  • post-op pain from de-horning
46
Q

withdrawal times are very important for flunixin**

A

:)

47
Q

phenylbutazone approved in which species

A

horses, dogs

48
Q

phenylbutazone select/non-select. COX-inhib?*

A

non-select.

49
Q

can you give phenylbutazone to animals intended for human consumption?**

A

NO!

50
Q

advantages of pheylbutazone

A

has good analgesic and antipyretic actions

51
Q

Tepoxalin approved in which species

A

dogs

52
Q

Tepoxalin acts on which enzymes?**

A

non-selective COX-1/COX-2 inhibitor + lipoxygenase (LOX) inhibitor. “DUAL-ACTING”
-inhibits formation of prostaglandins, Thromboxanes, and leukotrienes

53
Q

Tepoxalin advantages/disadvantages still widely unknown

A

:)